IPO Trending
SUDEEPPHRMEQ / NSE, BSEListed
Sudeep Pharma

Sudeep Pharma Limited, incorporated in 1989, is a global manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients, supplying over 200 products to customers in more than 100 countries. The company operates six manufacturing facilities with a total capacity of 50,000 MT, producing key minerals such as calcium, iron, magnesium, zinc, potassium, and sodium. With strong in-house R&D and pilot-scale labs, the company focuses on developing high-quality mineral salts and excipients across its pharmaceutical, food and nutrition, specialty ingredients, and triturates product segments. As of December 31, 2024, it employed 704 permanent staff.

₹563 - ₹59393.72x sub
Listed Price₹737.00
Listing Gain+24.28%

Subscription Status

93.72xTotal Demand
Updated 20 Oct 2026, 01:30 AM
QIB213.08x
🔥 Blockbuster Sizzling Demand!Offered: 30,18,553 sh
Nib116.72x
🔥 Blockbuster Sizzling Demand!Offered: 22,63,912 sh
Hnis(10l +)134.91x
🔥 Blockbuster Sizzling Demand!Offered: 15,09,275 sh
Hnis (2-10l)80.33x
🔥 Blockbuster Sizzling Demand!Offered: 7,54,637 sh
Retail15.65x
Hot Bidding (High Profits)Offered: 52,82,462 sh
CategoryOfferedAppliedTimes
QIB30,18,55364,31,88,450213.08x
Nib22,63,91226,42,40,950116.72x
Hnis(10l +)15,09,27520,36,19,700134.91x
Hnis (2-10l)7,54,6376,06,21,25080.33x
Retail52,82,4628,26,71,27515.65x

Segment Subscription Demand

Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB38,141.08179213.08x
Fiis11,221.950Open
Fis15,279.160Open
Mutual Funds1,698.70Open
Others9,941.260Open
Retail4,902.41313.2515.65x
Hnis 2+3,594.8444.7580.33x
Hnis 10+12,074.6589.5134.91x

Application-wise Breakup

CategoryReservedAppliedTimes Sub.
Retail2,11,29827,22,86312.89x
Hnis(10l +)4,3121,17,65527.29x
Hnis (2-10l)2,1561,64,60776.35x
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Sudeep Pharma IPO Subscription Demand

Live subscription status and bidding analysis for Sudeep Pharma (SUDEEPPHRM) IPO. The issue is subscribed 93.72x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions